Building upon this, McClements et al. developed a side-flow strip that incorporated up-conversion nanoparticles (UCNPs) and novel vascular biomarkers, such as FKBPL and CD44 proteins, in order to facilitate accurate and timely diagnosis of preeclampsia during pregnancy. This evidence concerns the gene FKBPL and preeclampsia.